Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 19, 2026 09:20 ET | Source: Bonafide® Health, LLC

Bonafide® Health Launches Noctera™ – A Novel, Hormone-Free Supplement Designed to Improve Sleep Quality and Duration Negatively Impacted by Hormonal Changes

New York, NY, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a women's healthcare company dedicated to providing science-backed solutions for perimenopause and menopause symptoms, has...
September 04, 2025 08:50 ET | Source: Bonafide® Health, LLC

Bonafide® Health Announces Expansion to Retail with Exclusive Launch into 1,800+ Target Stores and Target.com

New York, NY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Bonafide Health, LLC, a leading direct-to-consumer women’s healthcare company that provides clinically researched solutions to effectively relieve...
March 13, 2025 08:30 ET | Source: Femasys Inc.

Femasys Announces FemBloc Delivery System Approval in Europe; A Significant Step Towards FemBloc Permanent Birth Control Availability as the First-Ever Non-Surgical Approach

ATLANTA, March 13, 2025 (GLOBE NEWSWIRE) -- Femasys Inc., (Nasdaq: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad portfolio of...
August 27, 2024 08:30 ET | Source: Femasys Inc.

Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters

ATLANTA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
June 20, 2024 08:30 ET | Source: Femasys Inc.

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

ATLANTA, June 20, 2024 (GLOBE NEWSWIRE) -- Femasys, Inc., (Nasdaq: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...
May 16, 2024 08:30 ET | Source: Femasys Inc.

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council

ATLANTA, May 16, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of...